Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Post-Election Picture: Near-Term Next Steps To Come

This article was originally published in The Gray Sheet

Executive Summary

A guide to important health care policies and events expected in the short term, now that campaigning is done.

You may also be interested in...



Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session

Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.

Doc Payments For Coronary Stenting Will Drop Next Year, But Will Better Reflect Procedure Complexity

New coding structure for coronary stenting recognizes more complex procedure with higher levels of Medicare reimbursement, but overall physician payments for percutaneous coronary interventions will go down in 2013.

Key House Health Subcommittee Will Have New Leaders; Rep. Stark Loses Election Bid

House veteran Pete Stark, D-Calif., who served as ranking member of the House Ways and Means Health Subcommittee, was defeated in his re-election bid on Nov. 6. And Wally Herger, R-Calif., who chaired the subcommittee, already announced his plans to retire earlier this year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel